scispace - formally typeset
M

Mohinder K. Sardana

Researcher at United States Military Academy

Publications -  25
Citations -  2104

Mohinder K. Sardana is an academic researcher from United States Military Academy. The author has contributed to research in topics: Peptide sequence & Protease. The author has an hindex of 15, co-authored 25 publications receiving 2042 citations. Previous affiliations of Mohinder K. Sardana include Merck & Co..

Papers
More filters
Journal ArticleDOI

Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1

TL;DR: In this paper, photoaffinity labeling of presenilin 1 and 2 (PS1 and PS2) was performed by potent gamma-secretase inhibitors that were designed to function as transition state analogue inhibitors directed to the active site of an aspartyl protease.
Journal ArticleDOI

Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form

TL;DR: Experimental support is provided for the proposal that binding of an NS4A‐mimicking peptide, which increases catalytic rates, is necessary but not sufficient for formation of a well‐ordered, compact and, hence, highly active protease molecule.
Journal ArticleDOI

Activity of purified hepatitis C virus protease NS3 on peptide substrates.

TL;DR: Primary structure is an important determinant of the efficiency with which each site is cleaved during polyprotein processing, and slow cleavage of the NS4B-NS5A site in the absence of NS4A is due to low binding affinity of the enzyme for this site.
Journal ArticleDOI

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

TL;DR: Both doxorubicin and Leu-Dox were ineffective in reducing circulating PSA and tumor burden at their maximum tolerated doses and were selected for further study to assess their ability to inhibit human prostate cancer cell growth and tumorigenesis.